IL-17 and IFN-γ impact SLE by modulating autoantibody production through acting directly on B cells [36], or indirectly through recruiting inflammatory cells and stimulating of macrophages, synoviocytes, fibroblasts and neutrophils [37, 46]. This evidence concerns the gene IL17A and systemic lupus erythematosus.